Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 20.73B | 21.60B | 22.15B | 18.47B | 21.85B |
Gross Profit | 5.91B | 6.74B | 4.44B | 5.09B | 5.95B |
EBITDA | 896.00M | 1.48B | -425.00M | 810.00M | 1.02B |
Net Income | 235.00M | 679.00M | -1.07B | 178.00M | 444.00M |
Balance Sheet | |||||
Total Assets | 28.84B | 30.61B | 28.96B | 27.40B | 25.02B |
Cash, Cash Equivalents and Short-Term Investments | 4.20B | 6.78B | 4.48B | 5.66B | 6.13B |
Total Debt | 9.70B | 8.27B | 8.29B | 7.81B | 5.52B |
Total Liabilities | 15.18B | 16.93B | 16.25B | 13.69B | 11.54B |
Stockholders Equity | 13.66B | 13.69B | 12.71B | 13.71B | 13.49B |
Cash Flow | |||||
Free Cash Flow | -3.85B | 2.65B | -1.52B | -2.60B | 434.00M |
Operating Cash Flow | -3.52B | 2.96B | -1.19B | -1.62B | 1.16B |
Investing Cash Flow | -527.00M | -778.00M | -335.00M | -985.00M | -728.00M |
Financing Cash Flow | 1.10B | -246.00M | 272.00M | 2.06B | -708.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥46.01B | 12.61 | 4.62% | 3.23% | -22.14% | ||
80 Outperform | ¥24.32B | 6.88 | 0.71% | 7.38% | 25.90% | ||
80 Outperform | ¥4.21B | 4.09 | ― | 3.30% | 36.77% | ||
74 Outperform | ¥42.10B | 14.18 | 2.83% | -1.34% | -14.87% | ||
63 Neutral | $34.70B | 5.15 | -11.38% | 1.67% | 5.54% | -17.15% | |
58 Neutral | ¥6.15B | 28.81 | 3.02% | -1.17% | ― | ||
51 Neutral | ¥3.85B | 16.36 | 1.99% | -4.02% | -65.53% |